U.S. Markets close in 3 hrs 38 mins

Novartis’s Q2 2018 Estimates: Sandoz

Mike Benson
Novartis’s Q2 2018 Estimates: Sandoz

Sandoz represents Novartis’s (NVS) generic products, including pharmaceuticals and biotechnological active substances. Sandoz is expected to report growth in its second-quarter operating revenues. The chart below compares Sandoz’s revenues since the first quarter of 2017.